From lyophilization cycle development to the latest technologies and industry developments or innovations, our articles and case studies act as scientifically accurate, informative resources for all queries related to CDMO processes. The team at Biopharma Technology LLC, and the wider Biopharma Group, is keen to share the findings of our lyophilization services and practical experience to contribute to industry-wide conversations.
Browse our articles and resources section that includes posts, articles, app notes, case studies, videos, and booklet downloads to learn more about the specialist CDMO services that Biopharma Technology LLC can offer.
November 14, 2025
A leading PCR master mix producer partnered with Biopharma
Group to optimize their lyophilization process across five
formulations.
August 20, 2025
Our scientific team was asked to collaborate on a project with a U.S.-based client to support the development of an advanced Adeno-Associated Virus Serotype 5 (AAV5) vector-based gene therapy for the treatment of a rare genetic disorder. This project aimed to assess the long-term stability of both the gene therapy product and its formulation buffer, with the primary goal of enabling low-temperature storage while preserving product integrity and therapeutic efficacy.
June 10, 2025
A customer provided their freeze-dried RT-PCR assay in pellet format for robustness assessment and material property evaluation. Their goal was to determine whether their product was physically robust enough to meet the necessary quality control requirements.
February 13, 2025
November 19, 2024
